This is excellent news. Liberum are very “ grown up “ brokers and this indicates that all is going very well with the Phase 3 testing. This could be the first step with the American market in mind. I think that the market has interpreted this wrong and the current share price and any further weakening presents an exceptional buying opportunity. GLA.
Clearly Lombard Odier putting the screws on. Alternatively buying and then selling and buying back again. Some might call it rigging the market but probably considered fair play within the City’s code of conduct the intention no doubt ultimately to appear as a White Knight who will endeavour to provide the required funds circa 10 p and ultimately take their holding up to about 25 % We can at least gain some comfort that they must have some regard for the Company otherwise they wouldn’t bother.
Some entertaining if scurrilous comments about the present situation in the main from punters who have no right to be investing in an AIM company. Mind your language Guys otherwise you might end up on the wrong end of a Norwich Pharmacal order. It would appear that some are so blind with rage and hatred for JB that they have failed to notice that he waived the bonus to which he was fully entitled last year. As and when a fund raising is made suggest you wait and see where any additional funds come from before commenting as to who should do what and when. In the meantime keep buying the shares and have an enjoyable weekend. Arturo.
MED 2002 has already been clinically proven to work at 0.2%in mild ED patients. These results have been reported in the Peer reviewed Journal of Sexual Medicine. If it had NOT worked the Journal would never have reported the efficacy. YEs, there is a placebo effect on rubbing your penis with either an active or placebo gel - but that is hardly surprising ! The Company showed how great the PK results were by doubling and trebling the dose by which they get roughly twice and three times the active absorbed at the same speed as the lower dose and with a similar safety profile. The P3 study therefore stands a great chance of improved efficacy in the moderate and severe ED patients and therefore commercial success. As to the last 48 hours it looks as if there has been some Institutional short selling to force the price down prior to fund raising and some of the PI “lemmings “ have panicked but only they have lost money as they were foolish enough to sell. This presents us long term Fumsters a golden opportunity to get in at a ridiculously low price. Back to 20 by the end of next week ? More than likely. GLA.
Good to meet Farmer Giles twin brother. Seems a sensible chap and rather less arrogant than his brother was on II.
If further funding is required it will most likely be a placing and probably for not very much. If that is the case then let’s hope that us long standing faithful Fumsters might get a sniff at picking up some shares in the low 20s. Could be the last chance of picking up cheap stock, if Phase 3 results this time next year hit the jackpot.
Why ? With Phase 3 starting at the end of this month Futura will obviously press on to get MED 2002 fully approved before entering into serious discussions regarding a deal. Big pharma want certainty and are just not interested in “ Buying In “ prior to approval see past failures with RB and C and D. Futura may have to raise a bit of cash to ensure funds are fully available but it shouldn’t be much and certainly shouldn’t be a problem.